Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions

Clinical trial NCT00560066 · COMPLETED

Trial details

NCT number: NCT00560066
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Seasonal Influenza Vaccine

Start date: 2007-11-01
Primary completion: 2008-07-01
Enrollment: 1398

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.